Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
OKYO-0101 by OKYO Pharma for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
OKYO-0101 is under clinical development by OKYO Pharma and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...
Data Insights
OKYO-0101 by OKYO Pharma for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
OKYO-0101 is under clinical development by OKYO Pharma and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...